These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3194355)

  • 41. [Deviations of calcium and phosphorus metabolism in postmenopausal osteoporosis].
    Yoshikawa S
    Nihon Rinsho; 1982; 40(12):2738-44. PubMed ID: 6761467
    [No Abstract]   [Full Text] [Related]  

  • 42. Triphasil--a new triphasic oral contraceptive.
    Med Lett Drugs Ther; 1985 May; 27(688):48. PubMed ID: 4000059
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
    Crilly R; Horsman A; Marshall DH; Nordin BE
    Aust N Z J Med; 1979 Feb; 9(1):24-30. PubMed ID: 313208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term calcitonin therapy in postmenopausal osteoporosis.
    Gruber HE; Ivey JL; Baylink DJ; Matthews M; Nelp WB; Sisom K; Chesnut CH
    Metabolism; 1984 Apr; 33(4):295-303. PubMed ID: 6423929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Interdisciplinary diagnosis and therapy concepts in climacteric osteoporosis].
    Löttge M; Spieler W; Seifert B; Hemp O
    Zentralbl Gynakol; 1989; 111(12):800-6. PubMed ID: 2475002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
    Sorensen OH; Lund B; Friis TH; Hjorth L; Reimann I; Kjaer I; Andersen RB
    Isr J Med Sci; 1977 Mar; 13(3):253-8. PubMed ID: 852974
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The use of the triphasic contraceptive preparation trisiston for therapeutic purposes].
    Vasilev D; Katsarova M; Dikov I; Rachev E
    Akush Ginekol (Sofiia); 1990; 29(1):79-83. PubMed ID: 2372104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Involutional osteopathies: the clinical x-ray, biochemical and hormonal aspects of the diagnosis].
    Bukhman AI; Zarubina NA; Dorokhova II; Kniazeva AP; Konnova EV
    Probl Endokrinol (Mosk); 1988; 34(4):7-12. PubMed ID: 3194359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
    Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
    Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observations with anteovin in dermatological disorders.
    Vánkos J
    Ther Hung; 1986; 34(4):204-11. PubMed ID: 2966994
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS; Sevastikoglou JA; Lindgren U
    Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of porcine calcitonin on calcium metabolism in osteoporosis.
    Cohn SH; Dombrowski W; Hauser W; Klopper J; Atkins HL
    J Clin Endocrinol Metab; 1971 Nov; 33(5):719-28. PubMed ID: 5166454
    [No Abstract]   [Full Text] [Related]  

  • 53. Femodene/Minulet--how different is gestodene?
    Drug Ther Bull; 1990 May; 28(11):41-2. PubMed ID: 2131208
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of 1-alpha oxyvitamin D3 on bone tissue in systemic osteoporosis].
    Rodionova SS; Zatsepin ST; Shvets VN
    Ortop Travmatol Protez; 1989 Feb; (2):37-40. PubMed ID: 2726218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Calcitonin, calcium lactate-gluconate + potassium phosphate, calcium phosphate: changes induced in the biology of the patient with multiple fractures].
    de Bastiani G; Nogarin L; Perusi M
    Clin Ortop; 1974; 25(4):199-204. PubMed ID: 4471239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Long term treatment of osteoporosis with thyrocalcitonin. Apropos of 7 cases].
    Bloch-Michel H; Milhaud G; Coutris G; Waltzing P; Charret A; Morin Y; Verger D; Dussart N
    Rev Rhum Mal Osteoartic; 1970 Oct; 37(10):629-38. PubMed ID: 5482813
    [No Abstract]   [Full Text] [Related]  

  • 57. The value of bone scintigraphy in the follow-up of vertebral osteoporosis.
    Rico H; Merono E; Del Olmo J; Revilla M
    Clin Rheumatol; 1991 Sep; 10(3):298-301. PubMed ID: 1790640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intestinal absorption of calcium-47 after treatment with oral oestrogen-gestogens in senile osteoporosis.
    Caniggia A; Gennari C; Borrello G; Bencini M; Cesari L; Poggi C; Escobar S
    Br Med J; 1970 Oct; 4(5726):30-2. PubMed ID: 5470432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of calcium infusions in patients with postmenopausal osteoporosis.
    Walton J; Dominquez M; Bartter FC
    Metabolism; 1975 Jul; 24(7):849-54. PubMed ID: 1138159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.